Search filters

List of works by Fred Poordad

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

scientific article

A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1.

scientific article published on 22 February 2013

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

scientific article published on 11 April 2014

Absence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants

scientific article published on 15 October 2009

An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

scientific article published on 3 February 2017

Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies

scientific article published on 19 July 2013

Big Changes Are Coming in Hepatitis C ⬇️

scientific article published on February 1, 2011

Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection ⬇️

scientific article published on October 10, 2012

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

scientific article published on 19 December 2013

Boceprevir for previously treated chronic HCV genotype 1 infection

scientific article

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

scientific article

Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response

scientific article published on May 2014

Comorbidities associated with the increasing burden of hepatitis C infection

scientific article published on 08 April 2010

Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis

scientific article published in May 2015

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

scientific article published on 11 January 2016

De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation ⬇️

scientific article published on November 1, 2003

Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis

scientific article published on September 2016

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

scientific article published on 4 August 2013

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

scientific article published on 23 January 2014

Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

scientific article

Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.

scientific article published in October 2007

Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy

scientific article

Emerging therapeutic options in hepatitis C virus infection

scientific article published on March 2011

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

scientific article published in February 2010

Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients ⬇️

scientific article published on November 4, 2011

Exploratory study of oral combination antiviral therapy for hepatitis C.

scientific article published on January 2013

Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection

scientific article published on 22 September 2014

Factors that predict response of patients with hepatitis C virus infection to boceprevir

scientific article published on 21 May 2012

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

scientific article published on May 2015

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

scientific article

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment

scientific article published on 27 January 2017

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

scientific article published on 12 April 2017

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

scientific article published on 20 November 2017

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

scientific article published on 19 September 2017

Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients

scientific article published on 31 August 2007

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis

scientific article published on 22 July 2016

High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

scientific article

Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study

scientific article published on 06 January 2014

Interferon Free Hepatitis C Treatment Regimens: The Beginning of Another Era ⬇️

scientific article published on February 1, 2012

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

scientific article

Ledipasvir/sofosbuvir-based treatment of patients with chronic genotype-1 HCV infection and cirrhosis: results from two Phase II studies.

scientific article

Management of Overt Hepatic Encephalopathy ⬇️

scientific article published on February 1, 2012

Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia ⬇️

scientific article published on February 25, 2011

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

scientific article published in December 2009

Morbidity in live liver donors: standards-based adverse event reporting further refined

scientific article

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

scientific article

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

scientific article

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

scientific article

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

scientific article published on 9 October 2013

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response

scientific article

Percutaneous liver biopsy after living donor liver transplantation resulting in fulminant hepatic failure: the first reported case of hepatic compartment syndrome

scientific article

Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.

scientific article published on January 2014

Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239.

scientific article published on 08 August 2016

Rapid virologic response: a new milestone in the management of chronic hepatitis C.

scientific article published on January 2008

Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient ⬇️

scientific article published on July 19, 2011

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

scientific article published on 29 June 2012

Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment

scientific article

Response-guided telaprevir combination treatment for hepatitis C virus infection

scientific article

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

scientific article published on 10 April 2014

Review: Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients ⬇️

scientific article published on March 1, 2009

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

scientific article published on 30 July 2016

Rifaximin treatment in hepatic encephalopathy

scientific article

Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials

scientific article

Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis

scientific article

Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial

scientific article

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

scientific article published on November 2013

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 4 June 2014

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

scientific article

Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus

scientific article published on 21 February 2017

Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks

scientific article published on 14 October 2015

The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).

scientific article published on September 2015

Thrombocytopenia associated with chronic liver disease

scientific article

Treatment of Hepatitis C Virus Genotype 3 Infection

scientific article published on October 2015

Viral resistance in hepatitis B: prevalence and management

scientific article

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

scientific article published on October 2010

Paulina is supported by:

About Paulina

Help